Sun J, Yuan H, Sun L, Zhao L, Wang Y, Hou C
Acta Pharm Sin B. 2025; 15(1):188-204.
PMID: 40041915
PMC: 11873606.
DOI: 10.1016/j.apsb.2024.10.016.
Hertel A, Storchova Z
Biomolecules. 2025; 15(2).
PMID: 40001547
PMC: 11852650.
DOI: 10.3390/biom15020244.
Hyun K, Ahn J, Kim H, Kim J, Kim Y, Park H
Nat Commun. 2024; 15(1):9614.
PMID: 39511190
PMC: 11544104.
DOI: 10.1038/s41467-024-53981-0.
Bae A, Zheng Y
Biochem Soc Trans. 2024; 52(5):2193-2201.
PMID: 39324605
PMC: 11624628.
DOI: 10.1042/BST20240242.
Xiong X, Pan X, Luo X, Wang Y, Zhang X, Yang S
Theranostics. 2024; 14(11):4297-4317.
PMID: 39113798
PMC: 11303085.
DOI: 10.7150/thno.96375.
Exploring the Role of GITR/GITRL Signaling: From Liver Disease to Hepatocellular Carcinoma.
Papadakos S, Chatzikalil E, Vakadaris G, Reppas L, Arvanitakis K, Koufakis T
Cancers (Basel). 2024; 16(14).
PMID: 39061246
PMC: 11275207.
DOI: 10.3390/cancers16142609.
CARM1 hypermethylates the NuRD chromatin remodeling complex to promote cell cycle gene expression and breast cancer development.
Chen X, Huang M, Fan D, He Y, Zhang W, Ding J
Nucleic Acids Res. 2024; 52(12):6811-6829.
PMID: 38676947
PMC: 11229315.
DOI: 10.1093/nar/gkae329.
The emerging role of CARM1 in cancer.
Xie Z, Tian Y, Guo X, Xie N
Cell Oncol (Dordr). 2024; 47(5):1503-1522.
PMID: 38619752
PMC: 11466993.
DOI: 10.1007/s13402-024-00943-9.
Downregulated RBM5 Enhances CARM1 Expression and Activates the PRKACA/GSK3β Signaling Pathway through Alternative Splicing-Coupled Nonsense-Mediated Decay.
Zhang Y, Li F, Han Z, Teng Z, Jin C, Yuan H
Cancers (Basel). 2024; 16(1).
PMID: 38201567
PMC: 10778212.
DOI: 10.3390/cancers16010139.
Enhanced Transcriptional Signature and Expression of Histone-Modifying Enzymes in Salivary Gland Tumors.
Manou M, Loupis T, Vrachnos D, Katsoulas N, Theocharis S, Kanakoglou D
Cells. 2023; 12(20).
PMID: 37887281
PMC: 10604940.
DOI: 10.3390/cells12202437.
PRMT1 promotes the proliferation and metastasis of gastric cancer cells by recruiting MLXIP for the transcriptional activation of the β-catenin pathway.
Wang F, Chen S, Peng S, Zhou X, Tang H, Liang H
Genes Dis. 2023; 10(6):2622-2638.
PMID: 37554218
PMC: 10404965.
DOI: 10.1016/j.gendis.2023.02.006.
Inhibition of CARM1 suppresses proliferation of multiple myeloma cells through activation of p53 signaling pathway.
Yang L, Ma L, Gong Q, Chen J, Huang Q
Mol Biol Rep. 2023; 50(9):7457-7469.
PMID: 37477799
PMC: 10460731.
DOI: 10.1007/s11033-023-08645-5.
Structural assessment of the full-length wild-type tumor suppressor protein p53 by mass spectrometry-guided computational modeling.
Ianni A, Tuting C, Kipping M, Ihling C, Koppen J, Iacobucci C
Sci Rep. 2023; 13(1):8497.
PMID: 37231156
PMC: 10213020.
DOI: 10.1038/s41598-023-35437-5.
In vivo RNA-seq and ChIP-seq analyses show an obligatory role for the C terminus of p53 in conferring tissue-specific radiation sensitivity.
Resnick-Silverman L, Zhou R, Campbell M, Leibling I, Parsons R, Manfredi J
Cell Rep. 2023; 42(3):112216.
PMID: 36924496
PMC: 10200257.
DOI: 10.1016/j.celrep.2023.112216.
coactivator associated arginine methyltransferase 1 (SmCARM1) effect on parasite reproduction.
Coelho F, Gava S, Andrade L, Assis Geraldo J, Tavares N, Lunkes F
Front Microbiol. 2023; 14:1079855.
PMID: 36910171
PMC: 9998485.
DOI: 10.3389/fmicb.2023.1079855.
Relationship Between Genetic Polymorphisms in Cell Cycle Regulatory Gene TP53 and Polycystic Ovarian Syndrome: A Case-Control Study and In Silico Analyses.
Biglari-Zadeh G, Sargazi S, Mohammadi M, Ghasemi M, Majidpour M, Saravani R
Biochem Genet. 2023; 61(5):1827-1849.
PMID: 36856940
DOI: 10.1007/s10528-023-10349-1.
The ULK3 kinase is a determinant of keratinocyte self-renewal and tumorigenesis targeting the arginine methylome.
Goruppi S, Clocchiatti A, Bottoni G, Di Cicco E, Ma M, Tassone B
Nat Commun. 2023; 14(1):887.
PMID: 36797248
PMC: 9935893.
DOI: 10.1038/s41467-023-36410-6.
Lactate-Lactylation Hands between Metabolic Reprogramming and Immunosuppression.
Chen L, Huang L, Gu Y, Cang W, Sun P, Xiang Y
Int J Mol Sci. 2022; 23(19).
PMID: 36233246
PMC: 9569569.
DOI: 10.3390/ijms231911943.
LYL1 facilitates AETFC assembly and gene activation by recruiting CARM1 in t(8;21) AML.
Chen Q, Cevher M, Jiang Q, Wang S, Sun X, Roeder R
Proc Natl Acad Sci U S A. 2022; 119(42):e2213718119.
PMID: 36215477
PMC: 9586329.
DOI: 10.1073/pnas.2213718119.
The synergistic interaction landscape of chromatin regulators reveals their epigenetic regulation mechanisms across five cancer cell lines.
Cao M, Wang L, Xu D, Bi X, Guo S, Xu Z
Comput Struct Biotechnol J. 2022; 20:5028-5039.
PMID: 36187922
PMC: 9483781.
DOI: 10.1016/j.csbj.2022.09.008.